San­doz to ex­pand its pres­ence in Slove­nia with new $400M plant

Gener­ics man­u­fac­tur­er San­doz has com­mit­ted rough­ly $400 mil­lion to con­struct a new plant in Eu­rope.

San­doz has agreed to build a new bi­o­log­ics plant in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.